Page last updated: 2024-08-21

3-methylglutaric acid and Cognition Disorders

3-methylglutaric acid has been researched along with Cognition Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anikster, Y; Ben-Zeev, B; Blumkin, L; Hassin-Baer, S; Lerman-Sagie, T; Lev, D; Schweiger, A; Sofer, S; Yahalom, G1
Costeff, H; Elpeleg, ON; Gibson, KM; Joseph, A; Shental, Y; Weitz, R1

Other Studies

2 other study(ies) available for 3-methylglutaric acid and Cognition Disorders

ArticleYear
The neuropsychological profile of patients with 3-methylglutaconic aciduria type III, Costeff syndrome.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2015, Volume: 168B, Issue:3

    Topics: Adult; Chorea; Cognition Disorders; Executive Function; Female; Follow-Up Studies; Humans; Intelligence; Male; Meglutol; Memory, Short-Term; Metabolism, Inborn Errors; Middle Aged; Neuropsychological Tests; Optic Atrophy; Prognosis; Psychomotor Performance; Spastic Paraplegia, Hereditary; Young Adult

2015
3-Methylglutaconic aciduria in the Iraqi-Jewish 'optic atrophy plus' (Costeff) syndrome.
    Developmental medicine and child neurology, 1994, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Child; Child, Preschool; Cognition Disorders; Female; Glutarates; Humans; Iraq; Jews; Male; Meglutol; Movement Disorders; Optic Atrophy; Syndrome

1994